CellSystems and ATERA to expand their on-going collaboration by co-marketing ATERA’s ‘on demand’ advanced 3D-tissue model R&D and specialized contract research services. On July 3, 2017, CellSystems Biotechnologie Vertrieb GmbH (Troisdorf, Germany) and ATERA SAS (Sophia Antipolis, France) announced a close collaboration for the commercialization of the epiCS® human skin models, including human epidermis, tanned epidermis and full thickness skin. […]

EINDHOVEN, Netherlands By introducing a tailor-made supply chain solution from MAG45, Thermo Fisher Scientific has fully optimized its supply chain and production processes. Although Thermo Fisher was initially dealing with a fragmented supply chain, the company can now focus on its core business thanks to improvement programs and a substantial reduction in the number of suppliers. […]

Nanomechanics Inc. is strengthening its worldwide presence through a partnership with Wales-based Scanwel. The exclusive agreement covers the distribution of our nanoindentation instruments throughout the U.K. and Ireland. Scanwel has more than 40 years of experience in the manufacturing and sales of complex vacuum systems and scientific instruments. “We are very excited to be working with them,” […]

Company expands portfolio of next-generation sequencing immuno-oncology and liquid biopsy assays to meet demand for a multi-disciplinary approach to cancer research AMSTERDAM and MADRID and CARLSBAD, Calif. — Thermo Fisher Scientific has formed the Immuno-Oncology Consortium to drive adoption of highly sensitive, next-generation sequencing (NGS) clinical research panels designed to help identify predictive and prognostic biomarkers associated with cancer immunotherapy. Recognizing […]

Company expands portfolio of next-generation sequencing immuno-oncology and liquid biopsy assays to meet demand for a multi-disciplinary approach to cancer research AMSTERDAM and MADRID and CARLSBAD, Calif. — Thermo Fisher Scientific has formed the Immuno-Oncology Consortium to drive adoption of highly sensitive, next-generation sequencing (NGS) clinical research panels designed to help identify predictive and prognostic biomarkers associated with cancer immunotherapy. Recognizing […]

SAN JOSE, CA, and SEATTLE, WA Labcyte Inc. and SEngine Precision Medicine today announced the companies are collaborating to fulfill the promise of personalized medicine by employing Labcyte’s advanced acoustic liquid handling solutions with SEngine’s unique functional drug testing approach with the mission to match cancer patients to the most effective and least toxic therapies available. SEngine employs functional […]

JEOL Ltd. (President Gon-emon Kurihara) is pleased to announce the “JEOL-Nikon CLEM Solution Center”, a collaborative project between Nikon and JEOL Ltd., will be established on September 1, 2017. The center will be opened in the R & D Building of JEOL to provide experience in and collect and deliver technical information on cutting-edge CLEM* […]

San Diego: Magritek, a leading provider of compact NMR and MRI instruments, and Quantum Design, a leading manufacturer and distributor of scientific and industrial instrumentation announce their new distribution partnership. Under the new agreement, Quantum Design South America will distribute Magritek’s product line of Spinsolve Benchtop NMR Spectrometers in South America. Commenting on the agreement, Andrew […]

Woolpit, United Kingdom: Deben, a leading provider of in-situ testing stages together with innovative accessories and components for electron microscopy, has been chosen by Phenom-World to supply the Microtest Tensile Stage as an accessory to their Phenom XL range of desktop scanning electron microscopes. Phenom-World, the leading global supplier of desktop scanning electron microscopes (SEMs), […]

Project is first for MilliporeSigma’s Massachusetts BioReliance® End-to-End Solutions center Collaboration gives Angiex access to MilliporeSigma’s process development tools and technologies Billerica, Massachusetts — MilliporeSigma today announced a new collaboration with Angiex, Inc., Cambridge, Massachusetts, to support the biotechnology start-up’s ability to speed its lead oncology antibody drug candidate to clinical use. Angiex is developing an antibody-drug conjugate […]